-
Phones, Wearables Studied to Monitor Brain Disorders
27 April 2016. A project now underway in Europe plans to develop techniques for smartphones and wearable devices to monitor people with depression, epilepsy, and multiple sclerosis. The 5-year, €22 million ($US 25 million) initiative known as Remote assessment of disease and relapse – Central Nervous System, or Radar-CNS, is funded by the Innovative Medicines…
-
NeuroVive, Penn Partner on Traumatic Brain Injury
26 April 2016. A pharmaceutical company in Sweden is collaborating with University of Pennsylvania’s medical school in preclinical studies of a new drug that protects against long term damage caused by traumatic brain injury. Financial terms of the agreement between NeuroVive Pharmaceutical AB in Lund, Sweden and the university were not disclosed. NeuroVive develops drugs…
-
Genetic Techniques Quickly Build Crop Disease Resistance
26 April 2016. Plant scientists in the U.K. developed genetic engineering techniques that quickly clone resistance to plant diseases affecting wheat, soybeans, and potatoes. The techniques are described in articles appearing in the 25 April issue of the journal Nature Biotechnology (paid subscription required). Teams from the John Innes Centre and Sainsbury Laboratory in Norwich…
-
Medical Google Glass Start-Up Raises $17M in Venture Funds
25 April 2016. A company building a system that allows doctors to automatically create patient notes with Google Glass added $17 million in its second full round of venture funding. Augmedix Inc., a 2 year-old enterprise in San Francisco, says the new financing will enable the company to scale-up its service across the country to…
-
Trials to Test New Treatments for Inherited Alzheimer’s
25 April 2016. Clinical trials are planned to assess experimental treatments and new diagnostics for inherited forms of Alzheimer’s disease. The new studies, which extend earlier trials of drugs to treat inherited Alzheimer’s disease, are funded by a $4.3 million grant from Alzheimer’s Association in Chicago. Like the earlier trials, the new round of studies…
-
On the Road Again
21 April 2016. We’ll be traveling for the rest of the week, so Science & Enterprise will not have any posts today or Friday. We’ll resume our regular posting on Monday, 25 April. * * *
-
NIH Closes Two Clinical Facilities for Sterility Issues
20 April 2016. National Institutes of Health closed two of its clinical facilities found not in compliance with safety and quality standards that could put patients at risk. Facilities at NIH closed for not meeting Current Good Manufacturing Practice standards are a cell therapy production lab at National Cancer Institute and a production center for…
-
U.S. Energy Use Declines in 2015, Renewables Gain
20 April 2016. Energy use by Americans in their homes and businesses declined in 2015 from the previous year, due to a sharp drop in coal burned for electric power, among other factors. The findings were published in an annual accounting of national energy supply and demand by Lawrence Livermore National Laboratory, based on data…
-
Software Detects DNA Mutations in Single Cells
19 April 2016. A new computer program detects genetic variations in individual cells, rather than current methods that require analyzing DNA in millions of cells. The program, named Monovar, is described by geneticists and bioinformatics specialists at M.D. Anderson Cancer Center in the 18 April issue of the journal Nature Methods (paid subscription required). Monovar…
-
Nanoparticles Designed for Asthma, Allergy Treatments
19 April 2016. A technique for masking allergy or asthma treatments in biodegradable nanoparticles is shown in lab mice to quickly build a tolerance in the immune system for offending allergens. A medical and engineering team at Northwestern University in Chicago published its findings yesterday, 18 April, in Proceedings of the National Academy of Sciences…